RenovoRx, Inc.RNXTNASDAQ
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank17
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
-862.82%
↑ 77% vs avg
Percentile
P17
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
-3767.78%
Historical baseline
PeriodValueYoY Change
TTM-862.82%+96.6%
2024-25511.63%-
20230.00%-
20220.00%-
20210.00%-
20200.00%-
20190.00%-